View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
 PRESS RELEASE

Psychemedics Corporation Reports 2023 Financial Results

Psychemedics Corporation Reports 2023 Financial Results DALLAS, March 28, 2024 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD), the world’s leading provider of hair testing for drugs of abuse, announced today financial results for the year ended December 31, 2023. “2023 proved to be another challenging year due to the negative impact of major economic forces. The labor shortage continues and remains unprecedented in its severity and duration, having an adverse impact on our clients. Despite these challenges, my confidence in our potential continues to increase. As cost reducti...

 PRESS RELEASE

Biomerica InFoods IBS Data to be Presented at the Upcoming Digestive D...

Biomerica InFoods IBS Data to be Presented at the Upcoming Digestive Disease Week (DDW) 2024 Conference Collaborators at the University of Michigan will present new Data on InFoods® IBS in the DDW Irritable Bowel Syndrome (IBS) Clinical Session IRVINE, Calif., March 28, 2024 (GLOBE NEWSWIRE) -- Biomerica, Inc. (NASDAQ: BMRA), a global biomedical company at the forefront of innovative gastroenterology solutions, proudly announces that data from collaborators at the University of Michigan utilizing its groundbreaking inFoods IBS technologies will be presented in the IBS Clinical Sessio...

Init Innovation In Traffic Systems SE: 1 director

A director at Init Innovation In Traffic Systems SE bought 2,400 shares at 35.882EUR and the significance rating of the trade was 59/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the...

AKR Corporindo Tbk PT: 1 director

A director at AKR Corporindo Tbk PT bought 36,658,400 shares at 1,816.199IDR and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last tw...

NEXCOM AS: 1 director

A director at NEXCOM AS bought 150,000 shares at 2.000DKK and the significance rating of the trade was 54/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sho...

 PRESS RELEASE

Emergent BioSolutions Continues to Broaden Access, Awareness and Avail...

Emergent BioSolutions Continues to Broaden Access, Awareness and Availability of NARCAN® Nasal Spray to Help Save Lives from the Ongoing Opioid Crisis As the first-ever U.S. Food and Drug Administration (FDA) approved over-the-counter (OTC) naloxone in 2023, Emergent is working to expand access with NARCAN® Nasal Spray and build on its longstanding efforts with public interest entities across the country Hundreds of thousands of NARCAN® Nasal Spray cartons are available in over 32,000 retail locations in the U.S., and Emergent is working to increase reach into workplaces, businesses and oth...

 PRESS RELEASE

Regency Centers Invites You to Join Its First Quarter 2024 Earnings Co...

Regency Centers Invites You to Join Its First Quarter 2024 Earnings Conference Call JACKSONVILLE, Fla., March 28, 2024 (GLOBE NEWSWIRE) -- Regency Centers Corporation (“Regency Centers” or the “Company”) (NASDAQ: REG) will announce its First Quarter 2024 earnings results on Thursday, May 2, 2024, after the market closes. The Company’s earnings release and supplemental information package will be posted on the Investor Relations section of the Company’s website – . The Company will host an earnings conference call on Friday, May 3, 2024, at 11:00 a.m. ET. First Quarter 2024 Earnings Confer...

 PRESS RELEASE

Processa Pharmaceuticals to Present at the MedInvest Biotech and Pharm...

Processa Pharmaceuticals to Present at the MedInvest Biotech and Pharma Investor Conference HANOVER, MD, March 28, 2024 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage pharmaceutical company focused on developing the next generation of chemotherapeutic drugs to improve the efficacy and safety for patients suffering from cancer, announces that George Ng, Chief Executive Officer, will present a corporate update at the MedInvest Biotech and Pharma Investor Conference. David Young, Processa’s President of Research & Development...

 PRESS RELEASE

Abu Dhabi's Inaugural Autonomous Car Race Series Revolutionizes Fan Ex...

Abu Dhabi's Inaugural Autonomous Car Race Series Revolutionizes Fan Experience with Vislink and Focal Point VR The Series Represents a Milestone in Immersing Motorsport Audiences into the Action through Innovative Technology Abu Dhabi and Mt. Olive, New Jersey, March 28, 2024 (GLOBE NEWSWIRE) -- Abu Dhabi is set to become the epicenter of a technological revolution in motorsport entertainment as the A2RL (Abu Dhabi Autonomous Racing League) series, powered by an innovative partnership between Vislink Technologies, Inc. and Focal Point VR Ltd., prepares to launch its thrilling first sea...

 PRESS RELEASE

EQS-News: vbw Pressemitteilung zum Bayerischen BIP 2023: Bruttoinlands...

Emittent / Herausgeber: ibw – Informationszentrale der Bayerischen Wirtschaft e. V. / Schlagwort(e): Sonstiges/Sonstiges vbw Pressemitteilung zum Bayerischen BIP 2023: Bruttoinlandsprodukt tritt 2023 faktisch auf der Stelle 28.03.2024 / 13:10 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Bruttoinlandsprodukt tritt 2023 faktisch auf der StelleBrossardt: „Branchenstruktur im Freistaat verhindert Rezession“ (München, 28.03.2024). Die bayerische Wirtschaft ist nach Angaben des Bayerischen Landesamts für Statistik im vergangenen Jahr gew...

 PRESS RELEASE

Issue of Supplementary Prospectus

Issue of Supplementary Prospectus Issue of Supplementary Prospectus Seneca Growth Capital VCT Plc (the "Company") 28 March 2024 The Board of Seneca Growth Capital VCT Plc (the “Company”) is pleased to announce that the Company has today published a supplementary prospectus (the “Supplementary Prospectus”) relating to the offer for subscription for B ordinary shares of 1p each in the Company, details of which were set out in a prospectus issued by the Company on 24 August 2023 (the “Offer”). The Supplementary Prospectus relates to the publication of the annual report and financial statem...

 PRESS RELEASE

Molecular Templates Announces $9.5 Million Private Placement Offering ...

Molecular Templates Announces $9.5 Million Private Placement Offering and Agreement to Amend Second Tranche of July 2023 Purchase Agreement AUSTIN, Texas, March 28, 2024 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage biopharmaceutical company focused on the discovery and development of proprietary targeted biologic therapeutics, known as engineered toxin bodies, to create novel therapies with potent and differentiated mechanisms of action for cancer, announced today it has entered into a definitive amended and restated secu...

 PRESS RELEASE

Candel Therapeutics Reports Fourth Quarter and Full Year 2023 Financia...

Candel Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate Highlights On track for topline data from CAN-2409 phase 3 in localized intermediate/high risk prostate cancer, expected in Q4 2024Results from ongoing, first-in-human, phase 1b clinical trial of CAN-3110, in recurrent high-grade glioma, published in NatureCatalyst-rich 2024 paves way for transformational year NEEDHAM, Mass., March 28, 2024 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical stage biopharmaceutical company focused on developing...

 PRESS RELEASE

Tevogen Bio Reports Series A-1 Preferred Stock Investment at $10 Conve...

Tevogen Bio Reports Series A-1 Preferred Stock Investment at $10 Conversion Price WARREN, N.J., March 28, 2024 (GLOBE NEWSWIRE) -- ('Tevogen Bio') (: ), a clinical-stage specialty immunotherapy biotech pioneer developing off-the-shelf, genetically unmodified T cell therapeutics in virology, oncology, and neurology, has entered into a securities purchase agreement with an existing investor pursuant to which the investor agreed to purchase shares of newly designated Series A-1 Preferred Stock of the Company in lieu of Series A Preferred Stock that the investor earlier agreed to purchase, f...

 PRESS RELEASE

Agile Therapeutics Reports Fourth Quarter & Full Year 2023 Financial R...

Agile Therapeutics Reports Fourth Quarter & Full Year 2023 Financial Results and Provides Corporate Update Full Year 2023 Net Revenue Increased 80% from 2022 While OPEX Decreased 33% Twirla Demand and Factory Sales Up 121% and 114% Respectively in 2023 vs 2022 Company Completes Pay-Off of Debt Facility in First Quarter 2024 Twirla Demand Expected to Rebound in First Quarter 2024 from Decreased Demand in Fourth Quarter 2023 Management to Host Conference Call Today, Thursday, March 28, 2024 at 8:30 a.m. ET PRINCETON, N.J., March 28, 2024 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Pi...

 PRESS RELEASE

AIM ImmunoTech to Present at the MedInvest Biotech & Pharma Investor C...

AIM ImmunoTech to Present at the MedInvest Biotech & Pharma Investor Conference Live webcast presentation on Wednesday, April 3rd at 1:35 PM ET OCALA, Fla., March 28, 2024 (GLOBE NEWSWIRE) -- (NYSE American: AIM) (“AIM” or the “Company”) today announced that of AIM ImmunoTech, will present at the being held in New York, N.Y., on Wednesday, April 3, 2024, at 1:35 PM ET. In addition to the presentation, management will be available to participate in one-on-one meetings with qualified members of the investor community who are registered to attend the conference. For more information ab...

 PRESS RELEASE

Fresh Del Monte Named One of America’s Most Trusted Companies by Newsw...

MIAMI--(BUSINESS WIRE)-- (NYSE: FDP), one of the world’s leading vertically integrated producers, distributors, and marketers of fresh and fresh-cut fruits and vegetables, has been named for the third consecutive year. The company ranked No. 8 in the Food & Beverage category for consumer, investor, and employee trust, up from Nos. 13 and 14 in 2022 and 2023, respectively. This press release features multimedia. View the full release here: Presented by Newsweek and Statista Inc., the world-leading statistics portal and industry ranking provider, the prestigious award recognizes the Most Tru...

 PRESS RELEASE

Recommended Cash Offer by Keysight for Spirent Communications PLC

SANTA ROSA, Calif. & LONDON--(BUSINESS WIRE)-- Keysight Technologies (NYSE: KEYS), today announced its intention to acquire the entire issued and to be issued share capital of Spirent Communications PLC (London Stock Exchange Symbol: SPT) ("Spirent”) for a cash consideration of 199 pence per Spirent share which values Spirent at approximately £1,158 million (US$ $1,463 million1), on a fully diluted basis. Spirent shareholders will also be entitled to receive a special dividend of 2.5 pence per Spirent share, in lieu of any final dividend for the year ended 31 December 2023 (together with the c...

 PRESS RELEASE

Microchip Technology Expands Its Serial SRAM Portfolio to Larger Densi...

Microchip Technology Expands Its Serial SRAM Portfolio to Larger Densities and Increased Speeds Product line offers a lower-cost alternative to parallel SRAM with up to 4 Mb density and 143 MHz SPI/SQI™ communications CHANDLER, Ariz., March 28, 2024 (GLOBE NEWSWIRE) -- To address a common customer need for bigger and faster SRAM, Microchip Technology (Nasdaq: MCHP) has expanded its product line to include larger densities of up to 4 Mb and increased Serial Peripheral Interface/Serial Quad I/O™ Interface (SPI/SQI™) speed to 143 MHz. The 2 Mb and 4 Mb devices are designed to provide a lo...

 PRESS RELEASE

EXL hosts virtual data and AI event

EXL hosts virtual data and AI event EXL’s AI in Action will showcase how enterprises are making a real impact using data and AI to drive business impact NEW YORK, March 28, 2024 (GLOBE NEWSWIRE) -- EXL [NASDAQ: EXLS], a leading data analytics, digital operations, and solutions company, announced its upcoming data and AI virtual event, AI in Action, scheduled for April 24 from 10:00 a.m. to 12:00 p.m. ET. The event promises to be an immersive experience, bringing together clients, prospects, and industry experts to explore the transformative power of data and AI at scale. Rohit Kapoor...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch